QA: Intelgenx Technologies Corp in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2018_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 6,044,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,346,000
3 remainder_Assets 757,000
4 LiabilitiesCurrent 2,077,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,241,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,022,018
9 ResearchAndDevelopmentExpense 2,602,949
10 remainder_Expenses 1,785,637
11 remainder_Revenues 5,188,188
12 remainder_NetIncome -55,110
13 remainder_ComprehensiveNetIncome 3,729,363
  yvar yval
0 Assets 13,147,000
1 Liabilities 9,318,000
2 Expenses 8,410,604
3 Revenues 5,188,188
4 StockholdersEquity 3,829,000
5 NetIncome -3,277,526
6 ComprehensiveNetIncome -1,412,844
7 BaseVar 19,924,132
8 EconomicCapitalRatiobeforeLimitedLiability 0.617
9 EconomicCapitalRatio 1.99

Edgar->Model Mapping

Feature Distribution

Change over Time